Mint Venture Partners

Type

Venture Capital, Private equity

Status

Active

Location

Seoul, South Korea

Total investments

15

Average round size

20M

Portfolio companies

14

Rounds per year

3.75

Follow on index

0.07

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyArtificial IntelligenceMachine LearningHealth CareHealth DiagnosticsRoboticsManufacturingMedical DeviceLife ScienceBlockchain

Investor highlights

Industry focus
Biotech/Life SciencesHealthcareWellness & FitnessMedtech
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
15
Lead investments
0
Rounds per year
3.75
Follow on index
0.07
Investments by industry
  • Health Care (9)
  • Medical Device (5)
  • Biotechnology (4)
  • Robotics (2)
  • Machine Learning (2)
  • Show 13 more
Investments by region
  • United States (6)
  • South Korea (5)
  • United Kingdom (1)
  • Canada (1)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
26M
Group Appearance index
0.67

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Organoid Sciences 13 Jan 2022 Biotechnology, Medical, Biopharma Early Stage Venture 17M Kyonggi-do, Seongnam, South Korea
Sonic Incytes 07 Dec 2021 Health Care, Medical Device Early Stage Venture 7M British Columbia, Vancouver, Canada

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.